tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Stanton, 4 are a BUY (100%).
Analyst David Stanton, currently employed at JEFFERIES, carries an average stock price target met ratio of 66.67% that have a potential upside of 77.43% achieved within 617 days.
David Stanton’s has documented 7 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MESO, Mesoblast Ltd at 31-Aug-2023.
Analyst best performing recommendations are on MESO (MESOBLAST LTD).
The best stock recommendation documented was for MESO (MESOBLAST LTD) at 1/19/2021. The price target of $2.24 was fulfilled within 527 days with a profit of $7.21 (76.3%) receiving and performance score of 1.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$-5.14 (-25.52%)
$11
1 months 13 days ago
(19-Dec-2024)
3/3 (100%)
$-1.62 (-9.75%)
117
Hold
$12
$-8.14 (-40.42%)
4 months 8 days ago
(24-Sep-2024)
2/5 (40%)
$4.85 (67.83%)
417
Buy
7 months 12 days ago
(20-Jun-2024)
1/2 (50%)
$15.82 (220.33%)
64
Buy
$0.85
1 years 5 months 2 days ago
(31-Aug-2023)
2/3 (66.67%)
$-2.55 (-75.00%)
617
Sell
$3
$-17.14 (-85.10%)
$4
1 years 5 months 28 days ago
(04-Aug-2023)
5/5 (100%)
$-0.28 (-8.54%)
45
What Year was the first public recommendation made by David Stanton?
